Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma (CLARITY)
CLinical Decision-making, Prognosis, quAlity of Life and Satisfaction With caRe in patIents With Relapsed/refracTory Multiple mYeloma (CLARITY)
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
A observational or N/A phase clinical study on Multiple Myeloma, this trial is ongoing. The trial is conducted by Gruppo Italiano Malattie EMatologiche dell'Adulto and has accumulated 13 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting
Status: Unknown → Active Not Recruiting
-
Jan 2025 — Jul 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Jul 2022 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Oct 2021 — Jul 2022 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting
-
Apr 2019 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2017 — Jan 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gruppo Italiano Malattie EMatologiche dell'Adulto
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ancona, Italy , Bologna, Italy , Brindisi, Italy , Cagliari, Italy , Catania, Italy , Catanzaro, Italy , Cona, Italy , Cosenza, Italy , Florence, Italy , Lecce, Italy and 19 more locations